LLS 2024 Advocacy Town Hall
Cancer treatment is far too expensive. And the costs are highly unpredictable. At our 2024 LLS Advocacy Town we discussed how we can work together in 2024 to…
Cancer treatment is far too expensive. And the costs are highly unpredictable. At our 2024 LLS Advocacy Town we discussed how we can work together in 2024 to…
Solar panels will be the main source of renewable energy in 2030, and they’re mostly made in China. For the United States, the accelerating pace…
Grünen Club-Chefin Petrovic an Seite von Dr. Hamer kontra Anzeiger Kinder-Prim. Dr. Jürgenssen
Snippet from a talk at the Educational Symposia -ESI Colorado meetings. Great annual meetings that combine 4h of CME per day with free time to…
The T-cell engager CX-904 had a favorable safety profile when administered as monotherapy in patients with advanced or metastatic solid tumors.
The FDA has granted a breakthrough device designation to Teal Wand, an at-home screening test for cervical cancer.
The 17th Annual Hematologic Malignancies Demystified returns in 2025. Access our virtual CME conference and earn CME/CE credits with our renowned faculty. Led by conference…
Maurie Markman, MD, expands on the debate regarding the appropriate primary outcome end point for improved clinical benefit in a trial.
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve…
This Viewpoint discusses use of anti–PD-1 monotherapy as the primary treatment option for patients with treatment-naive metastatic melanoma staining positive for PD-L1 over dual checkpoint…
🙏Srimad Bhagavad Gita Chapter 14 Verse 19🙏The wise man transcends the three gunas of nature and experiences his unity with God.🙏Hare Krishna🙏